Efficacy of neo-adjuvant gemcitabine plus cisplatin (GC) in muscle-invasive urothelial cancer (UC)

被引：0
|
作者：
Dash, A. [1 ]
Pettus, J. A. [1 ]
Bochner, B. H. [1 ]
Dalbagni, G. [1 ]
Donat, S. M. [1 ]
Herr, H. W. [1 ]
Bajorin, D. F. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5077
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Gemcitabine and cisplatin neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma: Predicting response and assessing outcomes.
    Gandhi, Nilay M.
    Baras, Alexander S.
    Munari, Enrico
    Faraj, Sheila
    Reis, Leonardo O.
    Liu, Jen-Jane
    Kates, Max
    Hoque, Mohammad
    Berman, David
    Hahn, Noah M.
    Eisenberger, Mario A.
    Netto, George J.
    Schoenberg, Mark
    Bivalacgua, Trinity
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [42] Localized invasive bladder cancer: neo-adjuvant chemotherapy?
    Bellmunt, J.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2011, 78 : S1 - S3
  • [43] Multicenter prospective phase II trial of neoadjuvant (neo) dose dense gemcitabine and cisplatin (DD-GC) in patients (pts) with muscle-invasive bladder cancer (MIBC)
    Balar, Arjun Vasant
    Iyer, Gopa
    Milowsky, Matthew I.
    Huang, William C.
    Woods, Michael
    Donat, S. Machele
    Herr, Harry W.
    Dalbagni, Guido
    Bochner, Bernard H.
    Ostrovnaya, Irina
    Al-Ahmadie, Hikmat
    Rose, Tracy Lynn
    Riches, Jamie Cathleen
    Kania, Brooke Elizabeth
    Regazzi, Ashley Marie
    Mccoy, Asia S.
    Delbeau, Daniela
    Rosenberg, Jonathan E.
    Bajorin, Dean F.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [44] Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial
    Galsky, Matthew D.
    Daneshmand, Siamak
    Izadmehr, Sudeh
    Gonzalez-Kozlova, Edgar
    Chan, Kevin G.
    Lewis, Sara
    Achkar, Bassam El
    Dorff, Tanya B.
    Cetnar, Jeremy Paul
    Neil, Brock O.
    D'Souza, Anishka
    Mamtani, Ronac
    Kyriakopoulos, Christos
    Jun, Tomi
    Gogerly-Moragoda, Mahalya
    Brody, Rachel
    Xie, Hui
    Nie, Kai
    Kelly, Geoffrey
    Horwitz, Amir
    Kinoshita, Yayoi
    Ellis, Ethan
    Nose, Yohei
    Ioannou, Giorgio
    Cabal, Rafael
    Haines, G. Kenneth
    Wang, Li
    Mouw, Kent W.
    Samstein, Robert M.
    Mehrazin, Reza
    Bhardwaj, Nina
    Yu, Menggang
    Zhao, Qianqian
    Kim-Schulze, Seunghee
    Sebra, Robert
    Zhu, Jun
    Gnjatic, Sacha
    Sfakianos, John
    Pal, Sumanta K.
    NATURE MEDICINE, 2023, 29 (11) : 2825 - +
  • [45] Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial
    Matthew D. Galsky
    Siamak Daneshmand
    Sudeh Izadmehr
    Edgar Gonzalez-Kozlova
    Kevin G. Chan
    Sara Lewis
    Bassam El Achkar
    Tanya B. Dorff
    Jeremy Paul Cetnar
    Brock O. Neil
    Anishka D’Souza
    Ronac Mamtani
    Christos Kyriakopoulos
    Tomi Jun
    Mahalya Gogerly-Moragoda
    Rachel Brody
    Hui Xie
    Kai Nie
    Geoffrey Kelly
    Amir Horowitz
    Yayoi Kinoshita
    Ethan Ellis
    Yohei Nose
    Giorgio Ioannou
    Rafael Cabal
    Diane M. Del Valle
    G. Kenneth Haines
    Li Wang
    Kent W. Mouw
    Robert M. Samstein
    Reza Mehrazin
    Nina Bhardwaj
    Menggang Yu
    Qianqian Zhao
    Seunghee Kim-Schulze
    Robert Sebra
    Jun Zhu
    Sacha Gnjatic
    John Sfakianos
    Sumanta K. Pal
    Nature Medicine, 2023, 29 : 2825 - 2834
  • [46] Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial
    Moschini, Marco
    Necchi, Andrea
    Montorsi, Francesco
    EUROPEAN UROLOGY, 2024, 85 (05) : 500 - 501
  • [47] INCIDENCE, CHARACTERISTICS, AND IMPLICATIONS OF THROMBOEMBOLIC EVENTS IN PATIENTS WITH MUSCLE INVASIVE BLADDER CANCER UNDERGOING CISPLATIN BASED NEO-ADJUVANT CHEMOTHERAPY
    Patterson, Laurel
    Pandya, Rishikesh
    Margel, David
    Hotte, Sebastien J.
    Shayegan, Bobby
    Mukherjee, Som D.
    Pinthus, Jehonathan H.
    JOURNAL OF UROLOGY, 2013, 189 (04): : E590 - E591
  • [48] A risk score for the prognosis prediction of the muscle-invasive bladder cancer patients who received gemcitabine plus cisplatin chemotherapy
    Guo, Yupeng
    Dong, Jing
    Ji, Tao
    Li, Xiaoxia
    Rong, Shengzhong
    Guan, Hongjun
    AGING-US, 2022, 14 (23): : 9715 - 9729
  • [49] Neoadjuvant chemotherapy with gemcitabine and cisplatin for muscle-invasive bladder cancer: multicenter retrospective study
    Okabe, Ko
    Shindo, Tetsuya
    Maehana, Takeshi
    Nishiyama, Naotaka
    Hashimoto, Kohei
    Itoh, Naoki
    Takahashi, Atsushi
    Taguchi, Keisuke
    Tachiki, Hitoshi
    Tanaka, Toshiaki
    Masumori, Naoya
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2018, 48 (10) : 934 - 941
  • [50] Tislelizumab with gemcitabine and cisplatin as a neoadjuvant regimen for muscle-invasive bladder cancer: case series
    Wang, Ze
    Wang, Yapeng
    Wang, Shuo
    Ran, Qiang
    Peng, Song
    Zhang, Yao
    Zhang, Jun
    Zhang, Dianzheng
    Wang, Luofu
    Lan, Weihua
    Liu, Qiuli
    Jiang, Jun
    ANNALS OF MEDICINE AND SURGERY, 2024, 86 (01): : 245 - 251
12345